Kezban Berberoglu
- Especialização: Nuclear medicine physician
- 29 anos de experiência
- Fala:English, Turkish
- Consultas online: disponível
- Local de trabalho: Turquia, Istambul, Anadolu Medical Center
A Dra. Kezban Berberoglu é professora de medicina nuclear no Anadolu Medical Center em Istambul. Concluiu a sua formação na Johns Hopkins University School of Medicine em Baltimore. A Dra. Berberoglu especializa-se em oncologia nuclear e cardiologia nuclear. Trata cancros da tiroide e da próstata utilizando terapias com radioisótopos. É membro da Associação Europeia de Medicina Nuclear.
- Realiza terapias com Lutécio-177 e Actínio-225 para doentes oncológicos.
- Especialista em imagiologia PET-CT utilizando Gálio-68 para casos oncológicos.
- Membro do grupo de trabalho de cardiologia da Associação Turca de Medicina Nuclear.
- Trabalha num hospital classificado entre os 10 melhores do mundo pela MTQUA e afiliado à Johns Hopkins.
Explore pacotes com Dr. Kezban Berberoglu
Consulta online com Kezban Berberoglu
Avaliações de pacientes
Serviços do médico
- Terapia com iodo radioativo
- Terapia com Lutécio-177
- Terapia com Actínio-225
- PET-TC com Gálio 68 (DOTATATE)
- Tomografia PET-CT com Gálio 68 (DOTA)
- Rastreio do cancro
- PET/CT em português de Portugal é traduzido como PET/TAC
- PET-TC com Gálio 68(PSMA)
- Testes de função tiroideia (incluindo T3, T4, TSH)
Como estamos indo?
Qualificações
Nuclear Medicine Expertise
Dr. Berberoğlu treats patients using nuclear oncology and nuclear cardiology. She uses radioactive tracers to diagnose and treat various conditions. The specialist performs Radioiodine therapy for thyroid issues. Additionally, she provides advanced targeted treatments like Lutetium-177 and Actinium-225 therapies.
Lutetium-177 and Actinium-225 therapies use radioactive isotopes to target and destroy cancer cells while sparing healthy tissue. The doctor uses PET/CT imaging techniques to detect tumors. These include PET-CT with Gallium 68 for neuroendocrine and prostate cancers. She also performs thyroid function tests and cancer screenings.
Her research investigated the role of MIBI in bone marrow involvement for childhood cancers. MIBI is a radioactive tracer used in scans to identify abnormal cell activity in the bone marrow.
Professional Work Experience
- 2025 – Professor at Istanbul Aydın University, Turkey
- 2004 – Nuclear Medicine Specialist at Istanbul Medical Faculty, Turkey
- 2000–2004 – Research Assistant at Istanbul University, Nuclear Medicine Department
- 1997–2000 – Physician at İzmir Bornova Altındağ Health Center No.1, Turkey
Education and Training
- 2004 – Istanbul University, Istanbul Medical Faculty – Residency in Nuclear Medicine
- 2003 – Johns Hopkins University School of Medicine – Visiting Scholar in Radiology
- 1997 – Trakya University, Faculty of Medicine – Medical Degree, Turkey
Specialized Medical Courses
- Imaging and Targeting Receptors, Johns Hopkins Medical Institutes, USA
- PET/CT and SPECT/CT Imaging in Oncology, Johns Hopkins, USA
- SNM CT Case Review Workshop, Philadelphia, USA
- Nuclear Medicine Business Management, Siemens Academy, 2007
- Patient Focused Care and Leadership Training by Planetree, 2016
- European School of Nuclear Medicine (ESNM) 15th Seminar
- Brain Perfusion SPECT and Gated SPECT courses, Turkey
- Bone Mineral Densitometry Course, Turkey
- Clinical Problem Solving in Oncology Cases, Turkey
- Basic Radio-pharmacy Course, Turkey
- EANM Learning Course on PET/CT in Oncology, 2005
- Integrated Administration System Course, 2005
- Correlative Imaging and Reporting Course, 2011
Professional Memberships
- European Association of Nuclear Medicine (EANM)
- Turkish Society of Nuclear Medicine – Member of Cardiology and Oncology Work Groups
- Turkish Nuclear Medicine Association
Também pode interessar
Pagamento e Recompensas
Não pague por nossos serviços
Efetue o pagamento diretamente na clínica ou na conta bancária oficial dela.
Algumas clínicas podem exigir um depósito como parte de sua política.
Divida seus pagamentos com opções de parcelamento.
Ganhe recompensas por indicar amigos ao Bookimed.